# Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV

> **NCT00074399** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 775 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nevirapine
- **DRUG:** Nevirapine placebo

## Key facts

- **NCT ID:** NCT00074399
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 775 (ACTUAL)
- **Last updated:** 2009-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00074399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00074399, "Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00074399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*